S&P 500
(-0.04%) 5 431.60 points
Dow Jones
(-0.15%) 38 589 points
Nasdaq
(0.12%) 17 689 points
Oil
(-0.17%) $78.49
Gas
(-2.47%) $2.89
Gold
(1.31%) $2 348.40
Silver
(1.91%) $29.62
Platinum
(0.90%) $963.20
USD/EUR
(0.31%) $0.934
USD/NOK
(0.26%) $10.67
USD/GBP
(0.59%) $0.788
USD/RUB
(1.77%) $89.43

Realtime updates for Protagonist Therapeutics [PTGX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated14 Jun 2024 @ 16:00

-2.79% $ 33.39

Live Chart Being Loaded With Signals

Commentary (14 Jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -1.97% compare to its pairs and should correct downwards.
Profile picture for Protagonist Therapeutics Inc

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases...

Stats
Today's Volume 441 230
Average Volume 571 607
Market Cap 1.96B
EPS $3.41 ( Q1 | 2024-05-07 )
Next earnings date ( $-0.680 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 13.15
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0370 (0.11%)
AADI 0.60%
ABCL -3.00%
ABCM 0.04%
ABEO -0.44%
ABIO -1.19%
ABOS 0.00%
ABSI -8.92%
ABUS -0.63%
ABVX -0.29%
ACAD -1.19%
ACER -17.95%
ACET -6.90%
ACGN 1.29%
ACHL -0.55%
ACHV -3.73%
ACIU -9.94%
ACLX -2.47%
ACRV -6.09%
ACST 0.80%
ACXP -2.02%
ADAG -5.30%
ADAP -2.88%
ADGI 0.87%
ADIL 2.34%
ADMA -1.39%
ADPT -5.15%
ADTX -10.00%
ADVM -5.81%
ADXN 1.06%
AEON 2.21%
AEZS -3.37%
AFMD 0.14%
AGEN -3.38%
AGIO -5.69%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW 53.45%
AKBA -4.46%
AKRO -2.60%
AKTX 3.61%
AKUS 0.00%
ALBO 0.00%
ALDX -3.37%
ALEC -5.07%
ALGS -1.59%
ALKS -1.25%
ALLK -6.45%
ALLO -7.48%
ALLR -2.76%
ALNA 3.16%
ALNY 0.21%
ALPN 0.00%
ALPX 0.00%
ALRN -0.92%
ALT -7.56%
ALVR 0.16%
ALXN 0.00%
ALXO -4.62%
ALZN -19.70%
AMRN -3.37%
AMTI -3.13%
ANAB -1.98%
ANEB -4.55%
ANGN 0.00%
ANIX -4.04%
ANL 1.81%
ANNX -6.49%
ANPC -3.15%
APGE -4.59%
APGN 8.48%
APGNW 30.65%
APLM -2.24%
APLS -1.32%
APLT -3.99%
APM 0.89%
APOP 0.38%
APRE 0.81%
APTO -5.32%
APTX 3.17%
APVO -1.70%
ARAV -13.39%
ARCT -1.90%
ARDS 0.00%
ARDX -2.16%
ARGX -0.35%
ARNA 0.00%
ARPO -0.90%
ARQT -7.60%
ARTL 3.01%
ARTLW -27.14%
ARVN -2.95%
ARWR -2.49%
ASLN 2.22%
ASMB 1.72%
ASND -0.16%
ATAI 2.24%
ATHA -0.39%
ATHE -1.59%
ATHX -33.50%
ATNF -2.52%
ATOS -2.44%
ATRA -3.13%
ATXI 9.12%
ATXS -0.22%
AUPH 5.61%
AURA 1.81%
AUTL -0.66%
AVBP -0.69%
AVEO 0.00%
AVIR -2.43%
AVRO -2.72%
AVTE 0.16%
AVTX -3.53%
AVXL 1.07%
AXLA 0.00%
AXSM 1.54%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -3.93%
BCAB 1.27%
BCDA -7.59%
BCDAW -33.33%
BCEL -1.32%
BCLI 6.09%
BCRX -0.96%
BCTX 4.41%
BCTXW 8.08%
BCYC -4.94%
BDRX 0.10%
BDTX -3.24%
BEAM -1.47%
BFRA -2.91%
BGNE -2.28%
BIOR 3.79%
BIVI -5.37%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -1.78%
BLTE -0.28%
BLU 0.03%
BLUE -4.04%
BMEA -2.93%
BMRN -0.87%
BNOX -5.93%
BNTC -2.14%
BNTX -4.08%
BOLD -9.52%
BOLT -1.20%
BPMC -0.79%
BPTH 8.00%
BPTS -13.47%
BRNS -6.15%
BRTX -5.13%
BTAI -2.84%
BTTX 1.27%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 5.60%
CABA -15.13%
CADL -3.32%
CALA -37.50%
CALC -2.98%
CALT -2.17%
CAPR -2.27%
CARA -21.10%
CARM -2.56%
CASI 0.00%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -9.17%
CCCC -8.94%
CCXI 0.00%
CDAK 0.00%
CDIO -0.66%
CDIOW 3.36%
CDMO 2.68%
CDMOP 0.04%
CDT -10.89%
CDTTW 46.23%
CDTX -5.08%
CDXC -6.88%
CDXS -2.87%
CELC -2.02%
CELU 1.75%
CELUW -9.13%
CERC -1.68%
CERE -0.13%
CERO 5.65%
CEROW -15.49%
CFRX -27.95%
CGEM -13.39%
CGEN 0.98%
CGON -0.43%
CGTX -1.36%
CHMA -6.00%
CHRS -5.06%
CINC 0.00%
CING -4.59%
CINGW -8.54%
CKPT 3.41%
CLBS -16.75%
CLDX -4.83%
CLGN 1.99%
CLLS -3.85%
CLNN -3.26%
CLNNW -41.25%
CLRB -4.17%
CLSD -3.25%
CLSN -0.68%
CLVS 0.00%
CMMB -1.74%
CMND 2.78%
CMPI 0.00%
CMPX -4.31%
CMRA 0.40%
CMRAW 33.33%
CMRX 0.27%
CNCE 0.00%
CNSP -22.93%
CNST 0.00%
CNTA 2.52%
CNTB -2.44%
CNTX -0.51%
COCP -9.13%
COEPW -23.50%
COGT -6.18%
CORT -8.06%
COYA -7.46%
CPRX -1.76%
CRBP -5.28%
CRBU -7.25%
CRDF -4.59%
CRGX -2.68%
CRIS -4.35%
CRNX -3.33%
CRSP -2.61%
CRTX 2.63%
CRVO -3.80%
CRVS -3.77%
CSBR -1.95%
CTCX -0.50%
CTIC 0.06%
CTMX -5.48%
CTNM -3.56%
CTXR -0.32%
CUE -11.69%
CVAC -8.25%
CVKD 8.64%
CWBR 0.00%
CYAD -12.96%
CYCC 2.42%
CYCCP -1.79%
CYCN 32.47%
CYT -2.27%
CYTK 2.31%
CYTO -6.20%
DARE 3.31%
DAWN -2.40%
DBTX -0.81%
DBVT -4.09%
DFFN 10.28%
DICE 0.06%
DMAC 2.13%
DNLI -6.28%
DNTH -3.56%
DOMH -0.98%
DRMA -18.97%
DRMAW 0.00%
DRNA 0.00%
DRTS -1.08%
DRTSW -1.00%
DRUG -0.94%
DSGN -2.88%
DTIL -2.28%
DYAI -4.59%
EARS -1.77%
EDIT -7.83%
EDSA 0.89%
EFTR -9.42%
EFTRW 0.00%
EIGR 0.00%
ELAB -5.10%
ELDN 3.06%
ELEV -3.58%
ELOX 0.00%
ELTX -2.85%
ELVN -1.45%
ELYM 1.38%
ENGN -10.00%
ENGNW -7.06%
ENLV 0.69%
ENOB 1.79%
ENSC -1.79%
ENTA -4.39%
ENTO -8.00%
ENTX -0.48%
ENVB -1.33%
EPIX 15.98%
EPRX 0.92%
EPZM 0.00%
EQ -9.23%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.46%
ERNA -1.04%
ERYP 1.30%
ESLA 0.00%
ESLAW -9.25%
ETNB -5.60%
ETON -1.93%
ETTX 0.00%
EVAX -8.55%
EVGN -0.09%
EVLO 50.00%
EWTX -2.23%
EXAI 5.67%
EXEL -1.00%
EYEG 0.04%
EYEN 1.41%
EYPT 0.97%
FATE -3.99%
FBIO -5.08%
FBIOP -0.48%
FBLG -0.97%
FBRX 0.54%
FDMT -3.20%
FENC -1.74%
FGEN -3.45%
FHTX -6.42%
FIXX 0.77%
FMTX 0.00%
FNCH -4.00%
FOLD -4.74%
FREQ 4.76%
FRLN 0.15%
FRTX 0.55%
FSTX 0.00%
FTRE -2.96%
FULC -4.49%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -1.50%
GANX -34.39%
GBIO -19.88%
GBT 0.01%
GDTC -7.32%
GERN -0.20%
GHRS -5.22%
GLMD -3.93%
GLPG -1.09%
GLSI -0.61%
GLTO -2.57%
GLUE -4.49%
GLYC -2.77%
GMAB -0.83%
GMDA 0.00%
GMTX 0.00%
GNCA -85.71%
GNFT -13.89%
GNLX -0.84%
GNPX -10.70%
GNTA -4.79%
GOSS 0.64%
GOVX -14.29%
GOVXW 2.25%
GPCR -6.72%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -1.76%
GRTX -6.47%
GTHX -7.02%
GUTS -4.73%
GXGXW 41.67%
GYRE 0.00%
HALO -0.24%
HARP 0.09%
HCWB 0.90%
HEPA -6.02%
HGEN -84.62%
HILS 5.66%
HLVX 1.96%
HOOK -4.92%
HOTH -0.06%
HOWL -7.38%
HRMY -2.39%
HRTX -0.96%
HSTO 62.16%
HUMA -2.08%
HUMAW -9.05%
IBRX 1.53%
ICCC -0.71%
ICPT 0.21%
ICU 9.07%
ICUCW 2.67%
ICVX -0.91%
IDRA -23.04%
IDYA -2.11%
IFRX 2.63%
IGMS -8.31%
IKNA -1.13%
IKT -7.24%
IMAB -1.08%
IMCR -3.10%
IMGN 0.02%
IMGO 0.00%
IMMP -0.73%
IMMX -0.96%
IMNM -6.98%
IMNN -5.88%
IMPL -27.27%
IMRA 15.96%
IMRN -0.46%
IMRX -10.65%
IMTX 0.54%
IMTXW -2.70%
IMUX -3.25%
IMV 0.00%
IMVT -2.26%
INAB -35.12%
INBX -5.36%
INCY -0.93%
INDP 1.23%
INFI -52.38%
INKT -4.33%
INM -4.55%
INMB -6.50%
INO -3.81%
INSM 3.72%
INTS 1.88%
INVA -0.50%
INZY -2.27%
IOBT 2.34%
IONS -1.14%
IOVA -3.20%
IPA 0.00%
IPHA 0.43%
IPSC -3.99%
IRON 18.16%
ISEE 0.38%
ITOS -0.43%
ITRM -1.71%
IVA -6.31%
IVVD -7.06%
JAGX 9.16%
JANX -0.87%
JAZZ 0.19%
JNCE 0.00%
JSPR 2.79%
JSPRW 33.87%
JUNS 0.00%
JUNSW 0%
KA 9.59%
KALV -1.55%
KDNY 0.22%
KMPH -0.34%
KNSA 0.05%
KNTE -0.38%
KOD 1.81%
KPRX 10.74%
KPTI -6.23%
KRBP 1.92%
KRON 1.89%
KROS -0.28%
KRRO -2.12%
KRTX 0.03%
KRYS -2.70%
KTRA -1.98%
KTTA -2.95%
KTTAW -26.58%
KURA -3.48%
KYMR -4.53%
KYTX -34.00%
KZIA -5.08%
KZR -1.69%
LABP 0.57%
LBPH -7.17%
LBPS 0.00%
LBPSW 14.81%
LEGN -2.79%
LENZ -0.48%
LEXX -6.08%
LEXXW 0.00%
LGND -1.57%
LGNDV 0.00%
LGVN 18.59%
LIAN 0.00%
LIFE 2.70%
LIPO 1.63%
LIXT -3.16%
LIXTW 8.14%
LJPC -0.32%
LMNL 0.12%
LOGC -0.37%
LPCN 16.58%
LPTX -4.09%
LQDA -3.65%
LRMR -3.10%
LSTA 4.65%
LTRN -1.29%
LUMO -3.63%
LVTX -2.50%
LXEO -7.36%
LXRX -0.55%
LYEL -8.88%
LYRA -4.80%
MACK 0.00%
MBIO -4.97%
MBRX -5.91%
MCRB -0.30%
MDGL 0.21%
MDNA -13.16%
MDWD -4.04%
MDXG -1.16%
MEIP -1.02%
MESO -0.14%
MGNX -4.49%
MGTA -7.74%
MGTX -2.60%
MGX -7.50%
MIRM -2.85%
MIRO 0.59%
MIST -1.40%
MITO 0.00%
MLEC 2.80%
MLECW 0.00%
MLND -5.36%
MLTX -3.04%
MLYS -0.87%
MNKD -4.76%
MNMD -3.31%
MNOV -1.48%
MNPR 1.18%
MOLN 13.78%
MOR -1.52%
MORF -4.68%
MREO 6.52%
MRKR 3.09%
MRNA -3.58%
MRNS 0.34%
MRSN -6.76%
MRTX -0.17%
MRUS -1.91%
MRVI -3.09%
MTCR -1.29%
MTEM -6.79%
MTP -18.50%
MURA -2.12%
MYMD 1.86%
NAMS -1.29%
NAMSW -1.10%
NAUT -2.66%
NBRV 0.71%
NBSE -1.56%
NBTX -16.21%
NCNA -3.85%
NERV 1.22%
NEXI 2.08%
NGM -1.28%
NGNE 1.43%
NKGN 2.27%
NKGNW 39.76%
NKTR -6.40%
NKTX -3.53%
NLSP -1.98%
NLSPW -34.00%
NMRA -1.71%
NMTR -42.97%
NOVN -24.84%
NRBO -2.81%
NRIX -9.26%
NRSN -4.90%
NRSNW 9.09%
NRXP -11.92%
NRXPW 45.50%
NRXS -1.00%
NTBL -23.60%
NTEC -12.45%
NTHI 0%
NTLA -3.12%
NTRBW -6.25%
NUVL -1.52%
NVAX -4.32%
NVCT -0.88%
NVIV -34.28%
NXTC 0.00%
NYMX -0.05%
OABI 0.00%
OABIW -14.71%
OBIO 1.92%
OBSV 0.00%
OCEA -5.37%
OCGN -6.58%
OCS -0.67%
OCUL 14.09%
OCUP -1.79%
ODT -4.27%
OKYO -3.10%
OLMA -0.80%
OMER -4.02%
OMGA -3.33%
ONCO -1.73%
ONCR -3.08%
ONCS 31.87%
ONCT 7.12%
ONCY -0.97%
ONTX -0.47%
ONVO -3.64%
OPNT 0.00%
OPT -22.42%
ORGS 7.37%
ORIC -2.47%
ORMP -1.53%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.13%
OVID 2.81%
OYST 0.00%
PALI 2.20%
PASG -1.87%
PBLA -4.63%
PBM -4.19%
PBYI -6.33%
PCSA 6.06%
PCVX -1.45%
PDSB -7.17%
PEPG -1.32%
PGEN -4.12%
PHAR 3.99%
PHAS 0.00%
PHAT 3.65%
PHIO -0.07%
PHIOW 36.47%
PHVS 3.65%
PHXM -5.20%
PIRS 1.00%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.42%
PLUR -0.91%
PMN -1.02%
PMVP -4.02%
PNT 0.16%
PPBT -2.83%
PRAX -2.70%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK -8.08%
PRQR -1.68%
PRTA -4.49%
PRTC 2.51%
PRTG 0.73%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -6.10%
PSTX -3.16%
PTCT -2.95%
PTE -0.82%
PTGX -2.79%
PTIXW 0.00%
PULM 1.47%
PXMD 7.84%
PYPD -3.42%
PYXS -4.05%
QLGN 2.10%
QNCX 1.73%
QNRX -2.64%
QSI -4.86%
QSIAW -2.78%
QTTB -5.44%
QURE -6.86%
RAIN -1.63%
RANI -1.23%
RAPT -4.60%
RARE -9.44%
RCKT -4.37%
REGN 0.97%
RENB 13.10%
REPL -11.58%
RETA 0.02%
REUN -0.89%
REVB -2.21%
REVBU 3.46%
REVBW -9.22%
RGLS -2.82%
RGNX -5.12%
RIGL -2.15%
RLAY -6.58%
RLMD 0.00%
RLYB -6.93%
RNA -0.80%
RNAC -6.83%
RNAZ 1.69%
RNXT 12.38%
ROIV -1.11%
ROIVW 4.56%
RPHM -2.35%
RPRX -1.03%
RPTX -3.06%
RUBY 2.70%
RVLP -32.05%
RVMD -2.82%
RVMDW -30.00%
RVNC -5.05%
RVPH -2.67%
RVPHW 19.23%
RXDX 0.09%
RXRX -1.91%
RYTM -3.61%
RYZB 0.02%
RZLT -23.45%
SABS -2.48%
SABSW -20.32%
SAGE 4.35%
SANA -14.97%
SAVA -0.85%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 23.76%
SCPH 1.97%
SCPS 0.00%
SEEL -5.53%
SEER -1.66%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -10.15%
SGMT -13.57%
SGTX -2.56%
SIOX 22.63%
SLDB -7.17%
SLGL 4.77%
SLN -2.13%
SLNO -5.80%
SLRX -7.02%
SLS 3.45%
SMMT 3.71%
SNDX -2.85%
SNGX -2.17%
SNPX 8.98%
SONN -6.25%
SPPI -0.49%
SPRB -3.33%
SPRC -1.04%
SPRO -0.73%
SRNE 0.00%
SRPT -1.73%
SRRA 0.00%
SRRK 0.21%
SRZN -0.71%
STAB 0.00%
STOK -7.25%
STRO -10.13%
STSA 0.00%
STTK -9.50%
SURF -0.93%
SVRA 0.49%
SWTX -1.51%
SYBX -1.23%
SYRS 3.45%
TALS -0.73%
TARA -1.53%
TARS -6.52%
TBPH -1.17%
TCBP -1.89%
TCDA 0.00%
TCON 29.90%
TCRR 0.00%
TCRT -6.08%
TCRX -6.67%
TECH -1.31%
TENX -3.68%
TERN 2.76%
TFFP -2.51%
TGTX -1.25%
THRX 0.12%
TIL 1.06%
TLC 0.00%
TLSA 1.65%
TNGX 6.44%
TNXP 5.50%
TNYA -10.16%
TPST -4.29%
TRDA -4.07%
TRVI -4.33%
TRVN 0.00%
TSHA -4.80%
TSVT -3.42%
TTNP 6.44%
TVTX -0.97%
TYRA -2.07%
UBX -5.30%
UNCY -0.93%
URGN 9.71%
UTHR 0.16%
VACC 11.36%
VALN -6.33%
VAXX -5.10%
VBIV 2.55%
VBLT -8.77%
VCEL -2.45%
VCNX -4.79%
VCYT -3.76%
VERA -3.69%
VERU -3.01%
VERV -3.21%
VIGL -0.92%
VINC -1.38%
VIR -5.89%
VIRI 2.67%
VIRX 0.87%
VKTX -0.15%
VLON -13.04%
VNDA -4.00%
VOR -4.17%
VRCA -5.14%
VRDN -5.40%
VRNA -2.70%
VRPX -4.85%
VRTX 0.35%
VSTM -5.19%
VTGN 0.00%
VTVT -7.69%
VTYX 0.35%
VXRT -23.67%
VYGR -3.30%
VYNE 4.55%
VYNT 7.78%
WINT 3.68%
WVE -3.86%
XBIO -1.03%
XBIT -3.48%
XCUR -1.34%
XENE -2.08%
XERS -0.90%
XFOR -3.77%
XLO -2.86%
XLRN 0.00%
XNCR -3.43%
XOMA -5.32%
XOMAO 0.09%
XOMAP 0.12%
XRTX 0.48%
YMAB -1.16%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -5.08%
ZNTL -7.14%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-07 Waddill William D. Buy 8 000 Common Stock
2024-06-07 Waddill William D. Sell 8 000 Stock Option (right to buy)
2024-06-07 Waddill William D. Sell 8 000 Common Stock
2024-06-07 Patel Dinesh V Ph D Sell 35 000 Common Stock
2024-04-18 Ali Asif Sell 1 234 Common Stock
INSIDER POWER
60.23
Last 97 transactions
Buy: 2 569 640 | Sell: 468 541
Correlation (AI algo v.1.1b): Overvalued: 1.97% $34.05 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.40 (neutral)
Short: 0.94 (very strong)
Signal:(44.285) Expect same movement, but be aware

Protagonist Therapeutics Correlation

10 Most Positive Correlations
ICFI0.86
SRTS0.854
KYMR0.846
PPH0.846
CREX0.833
REYN0.829
REGN0.828
EOLS0.822
MRUS0.817
LRMR0.813
10 Most Negative Correlations
VALN-0.806

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Protagonist Therapeutics Correlation - Currency/Commodity

The country flag 0.08
( neutral )
The country flag 0.13
( neutral )
The country flag 0.00
( neutral )
The country flag 0.18
( neutral )
The country flag 0.00
( neutral )
The country flag -0.26
( neutral )

Protagonist Therapeutics Financials

Annual 2023
Revenue: $60.00M
Gross Profit: $56.69M (94.48 %)
EPS: $-1.390
FY 2023
Revenue: $60.00M
Gross Profit: $56.69M (94.48 %)
EPS: $-1.390
FY 2022
Revenue: $26.58M
Gross Profit: $25.55M (96.12 %)
EPS: $-2.52
FY 2021
Revenue: $27.36M
Gross Profit: $0.00 (0.00 %)
EPS: $-2.71

Financial Reports:

No articles found.

Protagonist Therapeutics Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Protagonist Therapeutics

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment of IBD and non-IBD indications. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 3.4961400032043 seconds
Number of API calls: 3
Number of DB calls: 9